According to a report by P&S Intelligence, the global autoimmune disease diagnostics market is projected to generate a revenue of $10,012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020–2030. The market is being driven by the increasing geriatric population, rising incidence of autoimmune diseases, growing initiatives taken by various government and private organizations for raising awareness regarding autoimmune diseases, discovery of biomarkers, and surging strategic developments among major players.
Request to view sample of this market research: https://www.psmarketresearch.com/market-analysis/autoimmune-disease-diagnostics-market-report/report-sample
On the basis of application, the autoimmune disease diagnostic market is divided into multiple sclerosis, rheumatoid arthritis (RA), systemic lupus erythematous, scleroderma, Sjogren’s syndrome, sarcoidosis, myasthenia gravis, and others. Out of all these, the RA division is projected to register the highest CAGR in the near future, which can be attributed to the rising awareness programs that are being organized by public and private organizations, growing cases of RA, and discovery of new biomarkers for the diagnosis of this diseases.
The objective of this research includes;
Geographically, North America is predicted to advance at the fastest pace in the coming years in the autoimmune disease diagnostics market. This can be owing to the widespread burden of autoimmune diseases, enhanced healthcare infrastructure, presence of established players, growing geriatric population, and rising research activities.
The major players operating in the autoimmune disease diagnostics market are Abbott Laboratories, Thermo Fisher Scientific Inc., bioMérieux S.A., Danaher Corporation, Siemens AG, Seramun Diagnostica GmbH, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Trinity Biotech plc, Exagen Inc., Cambridge Life Sciences Limited, , HYCOR Biomedical, Grifols S.A., ELITech Group, PerkinElmer Inc., Inova Diagnostics, Adaltis S.r.l., ORGENTEC Diagnostika GmbH, Bio-Rad Laboratories Inc., Sigma Diagnostics Inc., and A. Menarini Diagnostics S.r.l.
The research includes detailed analysis of;
Based on Product
Based on Test Type
Based on Application
Based on End User
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.